Methods and apparatus for treatment of parkinson's disease

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/70 (2006.01) A61K 31/19 (2006.01) A61K 31/198 (2006.01) A61K 31/216 (2006.01) A61K 47/10 (2006.01) A61K 47/12 (2006.01)

Patent

CA 2268455

A pharmaceutical composition for treatment of Parkinson's disease comprising a compound of levodopa dissolved in a non-degradative solvent which allows transdermal administration of levodopa. The compound of levodopa is an alkyl-ester of levodopa and the solvent is a formulation comprising a substantially non-aqueous solvent, a transdermal enhancer and a detergent. The alkyl-ester of levodopa is preferably levodopa-ethyl-ester (LDEE).

Une composition pharmaceutique de traitement de la maladie de Parkinson comprend un composé de lévodopa dissous dans un solvant non dégradant permettant l'administration transdermique de lévodopa. Le composé de lévodopa est un alkyl-ester de lévodopa et le solvant est une formulation comprenant un solvant sensiblement non aqueux, un activateur transdermique et un détergent. L'alkyl-ester de lévodopa est de préférence un lévodopa-éthyl-ester (LDEE).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Methods and apparatus for treatment of parkinson's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and apparatus for treatment of parkinson's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and apparatus for treatment of parkinson's disease will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1997609

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.